Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| BAP08-2025-5797 | Other Grant/Funding Number | Ondokuz Mayıs University Scientific Research Project |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main goal of this clinical trial is to determine the effect of flaxseed added to the diet on biochemical parameters and quality of life in patients with Type 2 diabetes mellitus (T2DM). The main questions it aims to answer are:
Researchers will compare patients with T2DM consume diet added flaxseed to a control group to see if flaxseed effect on biochemical parameters and quality of life.
Participants will:
Adult individuals between the ages of 19-65, with a body mass index (BMI) between 20-35 kg/m2, using oral anti-diabetics and not using insulin will be included in the study. Patients with T2DM who agree to participate in the study will be randomly assigned to the intervention or control group using the simple randomization method. Participants will be followed for 12 weeks. Both groups will receive diet as part of T2DM treatment. Subjects in the intervention group will consume 30 g of ground flaxseed per day in addition to their diet. The participants were asked by the researchers through a face-to-face interview technique to determine their demographic characteristics (age, marital status, education level, employment status, income level, etc.), quality of life short form (SF-36) scale, international physical activity questionnaire (IPAQ) and 3-day food consumption record. A survey form questioning consumption records will be applied at the baseline and end of the study. In addition, routinely monitored biochemical parameters of the patients will be recorded from the hospital system at the baseline and end of the study. Anthometric measurements will be taken and recorded by the researcher in accordance with the method. The data obtained will be evaluated in the SPSS package program.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Diet+Flaxseed | Experimental | Diet will be planned to patients with T2DM as a part of their medical nutritional therapy. This group will take 30 g/d ground flaxseed within their diet. |
|
| Diet | Experimental | Diet will be planned to patients with T2DM as a part of their medical nutritional therapy. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Flaxseed | Dietary Supplement | 30 g/day for 12 weeks |
| |
| Diet |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of the effect of flaxseed on fasting blood glucose (mg/dL) | From enrollment to the end of intervention at 12 weeks | |
| Evaluation of the effect of flaxseed on HbA1c (%) | From enrollment to the end of intervention at 12 weeks | |
| Evaluation of the effect of flaxseed on total triglyceride (mg/dL) | From enrollment to the end of intervention at 12 weeks | |
| Evaluation of the effect of flaxseed on total cholesterol (mg/dL) | From enrollment to the end of intervention at 12 weeks | |
| Evaluation of the effect of flaxseed on HDL-cholesterol (mg/dL) | From enrollment to the end of intervention at 12 weeks | |
| Evaluation of the effect of flaxseed on LDL-cholesterol (mg/dL) | From enrollment to the end of intervention at 12 weeks | |
| Evaluation of the effect of flaxseed on quality of life | Quality of life will be assessed with SF-36. The total score is evaluated separately into two summary scores: the physical component summary (PCS12) and the mental component summary (MCS12). The score of the answers related to the PCS12 is obtained from the factors of general health, role-physical, physical functioning, and bodily pain, and the score of the answers related to the MCS12 is obtained from the factors of social functioning, role-emotional, mental health, and energy/fatigue. Both scores range from 0 to 100, with a higher score representing better health. | From enrollment to the end of intervention at 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of the effect of flaxseed on BMI (kg/m2) | From enrollment to the end of intervention at 12 weeks | |
| Evaluation of the effect of flaxseed on waist circumference (cm) | From enrollment to the end of intervention at 12 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D008043 | Linseed Oil |
| D004032 | Diet |
| ID | Term |
|---|---|
| D005224 | Fats, Unsaturated |
| D005223 | Fats |
| D008055 | Lipids |
| D010938 | Plant Oils |
| D009821 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Behavioral |
Diet will be planned to patients with T2DM as a part of their medical nutrition therapy. |
|
| Evaluation of the effect of flaxseed on waist/hip ratio | From enrollment to the end of intervention at 12 weeks |
| D004700 | Endocrine System Diseases |
| Oils |
| D028321 | Plant Preparations |
| D001688 | Biological Products |
| D045424 | Complex Mixtures |
| D009747 | Nutritional Physiological Phenomena |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |